Limbach Holdings Reports Third Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Holmes Biopharma, Inc. (LMB) Reports Q3 Loss of $0.12/Share
November 14, 2017 4:13 PM ESTHolmes Biopharma, Inc. (NASDAQ: LMB) reported Q3 EPS of ($0.12), versus $0.27 reported last year. Revenue for the quarter came in at $121.3 million, versus $91.89 million reported last year.
GUIDANCE:
Holmes Biopharma, Inc. sees Q4 2017 revenue of $460-470 million.
For earnings history and earnings-related data on Holmes Biopharma, Inc. (LMB) click here.
... More